Successful treatment of severe heart failure in advanced diabetic kidney disease using angiotensin–neprilysin inhibitors (sacubitril/valsartan) – report of two cases with review of options in literature

Ratan Jha; Kiran K Mukku; Ambati K Rakesh; Sumeet Sinha

doi:10.4103/ijn.IJN_298_20

Advertisment

About us | Subscription | e-Alerts | Feedback | Login

| | | | |

Users Online:136

Official publication of the Indian Society of Nephrology

~ Next article

~ Previous article

~ Table of Contents

~ Similar in PUBMED

~ Search Pubmed for

~ Search in Google Scholar for

~Related articles

~ Citation Manager

~ Access Statistics

~ Reader Comments

~ Email Alert *

~ Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	523

Printed	12

Emailed	0

PDF Downloaded	28

Comments	[Add]

Click on image for details.

CASE REPORT

Year : 2021 | Volume : 31 | Issue : 6 | Page : 587-591

Successful treatment of severe heart failure in advanced diabetic kidney disease using angiotensin–neprilysin inhibitors (sacubitril/valsartan) – report of two cases with review of options in literature

Ratan Jha¹, Kiran K Mukku¹, Ambati K Rakesh¹, Sumeet Sinha²
¹ Department of Nephrology, Virinchi Hospital, Banjara Hills, Hyderabad, Telangana, India
² Department of Cardiology, Virinchi Hospital, Banjara Hills, Hyderabad, Telangana, India

Correspondence Address:
Ratan Jha
Department of Nephrology, Virinchi HospitaL, Road No. 1, Banjara Hills, Hyderabad - 500 034, Telangana
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/ijn.IJN_298_20

Patients with heart failure (HF) and advanced chronic kidney disease (CKD) constitute a special population that experience poor outcomes due to poor adherence to established therapies because of potential safety concerns. Role of newer agents like angiotensin–receptor neprilysin inhibitors (ARNI) in early stages of CKD is well elucidated. We report two cases of HF with reduced ejection fraction, who received ARNI in advanced stage of CKD (stage 5) and achieved remarkable outcomes in terms of quality of life and longevity.

[FULL TEXT] [PDF]*